Cogstate Limited provided earnings guidance for the he full year ended 30 June 2023. For the year, the company expects revenue to be in the range of $39 million - $41 million (9% - 12% below FY22); EBIT, from normal operations, is expected to be in the range of $1.0 million - $2.0 million; Net Profit before Tax, including restructure costs and interest revenue, is expected to be in the range of $0.6 million - $1.6 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 AUD | +1.21% | -10.71% | -13.49% |
04-01 | Cogstate Amends License Agreement with Eisai for Alzheimer’s Treatment | MT |
02-22 | Cogstate's Fiscal H1 Attributable Profit Jumps, Revenue Rises 3%; Shares Decline 8% | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.49% | 139M | |
+29.60% | 48.16B | |
-0.69% | 41.73B | |
+42.66% | 41.03B | |
-5.26% | 28.77B | |
+10.14% | 25.59B | |
-22.61% | 18.96B | |
+9.02% | 12.92B | |
+29.25% | 12.03B | |
-1.90% | 11.77B |
- Stock Market
- Equities
- CGS Stock
- News Cogstate Limited
- Cogstate Limited Provides Revenue Guidance in the Fourth Quarter 2023